Momentum Stocks

Array Biopharma on the Rise after Colorectal Cancer Trial Success

Array Biopharma on the Rise after Colorectal Cancer Trial Success

Array Biopharma Inc.’s (NASDAQ: ARRY) shares spiked 22.95 percent to close at $25.77 a share on Tuesday. The stock traded between $21.94 and $26.82 on volume of 20.03 million shares traded. Shares of Array Biopharma have soared nearly 85 percent in 2019. Array’s stocks was sent soaring after the company reported positive results from its Phase 3 BEACON CRC clinical […]